Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16094-31-8

Post Buying Request

16094-31-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16094-31-8 Usage

General Description

5-(1,1-dimethylethyl)salicylic acid (also known as TBSA) is a chemical compound that belongs to the class of salicylic acids. It is a derivative of salicylic acid, a commonly used ingredient in many skincare products due to its anti-inflammatory and exfoliating properties. TBSA has an additional tert-butyl group attached to the salicylic acid structure, which can enhance its stability and solubility in various formulations. 5-(1,1-dimethylethyl)salicylic acid is often used in cosmetic and pharmaceutical products for its ability to treat acne, unclog pores, and improve skin texture. Additionally, TBSA has been studied for its potential anti-aging and antioxidant effects, making it a versatile ingredient in the skincare industry.

Check Digit Verification of cas no

The CAS Registry Mumber 16094-31-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,9 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16094-31:
(7*1)+(6*6)+(5*0)+(4*9)+(3*4)+(2*3)+(1*1)=98
98 % 10 = 8
So 16094-31-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H14O3/c1-11(2,3)7-4-5-9(12)8(6-7)10(13)14/h4-6,12H,1-3H3,(H,13,14)

16094-31-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-tert-butyl-2-hydroxybenzoic acid

1.2 Other means of identification

Product number -
Other names 6-Oxy-3-tert.-butyl-benzol-carbonsaeure-(1)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16094-31-8 SDS

16094-31-8Relevant articles and documents

PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

-

Paragraph 00278-00279, (2019/06/17)

The disclosure provides processes for synthesizing compounds for use as CFTR modulators.

Synthesis and characterization of iron trisphenolate complexes with hydrogen-bonding cavities

Adelhardt, Mario,Chalkley, Matthew J.,Heinemann, Frank W.,Sutter, Joerg,Scheurer, Andreas,Meyer, Karsten

supporting information, p. 2763 - 2765 (2014/04/03)

A new family of C3-symmetric ligands, featuring phenolate donors and a secondary coordination sphere, have been synthesized. We report the synthesis and subsequent coordination chemistry of these new tripodal N-anchored tris(phenolate) chelates, [tris(5-tert-butyl-3-N-carboxamide-2-hydroxybenzyl) amines] (H3RSalAmi), to iron(II), iron(III), and zinc(II). These electron-rich complexes have intramolecular hydrogen bonds, and therefore the potential to stabilize biologically relevant substrates in small-molecule activation chemistry.

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Kohrt, Jeffrey T.,Filipski, Kevin J.,Cody, Wayne L.,Cai, Cuiman,Dudley, Danette A.,Van Huis, Chad A.,Willardsen, J. Adam,Rapundalo, Stephen T.,Saiya-Cork, Kamlai,Leadley, Robert J.,Narasimhan, Lakshmi,Zhang, Erli,Whitlow, Marc,Adler, Marc,McLean, Kirk,Chou, Yuo-Ling,McKnight, Cecile,Arnaiz, Damian O.,Shaw, Kenneth J.,Light, David R.,Edmunds, Jeremy J.

, p. 4752 - 4756 (2007/10/03)

The activated Factor VII/tissue factor complex (FVIIa/TF) plays a key role in the formation of blood clots. Inhibition of this complex may lead to new antithrombotic drugs. An X-ray crystal structure of a fluoropyridine-based FVIIa/TF inhibitor bound in the active site of the enzyme complex suggested that incorporation of substitution at the 5-position of the hydroxybenzoic acid side chain could lead to the formation of more potent inhibitors through interactions with the S1′/S2′ pocket.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16094-31-8